Terms: = Lymphoma AND TNFRSF14, Q92956, 8764, ENSG00000157873, TR2, ATAR, LIGHTR, HVEM, HVEA AND Treatment
18 results:
1. Follicular lymphoma Presenting With Symptomatic Bone Involvement: A Clinicopathologic and Molecular Analysis of 16 Cases.
Sarro R; Bisig B; Guey B; Missiaglia E; Cairoli A; Omoumi P; Letovanec I; Ferry JA; Hasserjian RP; de Leval L
Mod Pathol; 2024 Apr; 37(4):100440. PubMed ID: 38290600
[TBL] [Abstract] [Full Text] [Related]
2. The clinical and molecular taxonomy of t(14;18)-negative follicular lymphomas.
Salaverria I; Weigert O; Quintanilla-Martinez L
Blood Adv; 2023 Sep; 7(18):5258-5271. PubMed ID: 37561599
[TBL] [Abstract] [Full Text] [Related]
3. Genomic landscape of follicular lymphoma across a wide spectrum of clinical behaviors.
Mozas P; López C; Grau M; Nadeu F; Clot G; Valle S; Kulis M; Navarro A; Ramis-Zaldivar JE; González-Farré B; Rivas-Delgado A; Rivero A; Frigola G; Balagué O; Giné E; Delgado J; Villamor N; Matutes E; Magnano L; García-Sanz R; Huet S; Russell RB; Campo E; López-Guillermo A; Beà S
Hematol Oncol; 2023 Oct; 41(4):631-643. PubMed ID: 36994552
[TBL] [Abstract] [Full Text] [Related]
4. Transformation of FL into DLBCL with a PMBL gene expression signature.
Loveday T; Duns G; Rimsza LM; Rech KL; Cook JR; Robetorye RS; Rosenthal AC; Ramsower CA; Yip TK; McKinney CL; Swerdlow SH; Bhavsar S; Steidl C; Gibson SE
Blood Adv; 2023 Mar; 7(6):893-899. PubMed ID: 36240289
[TBL] [Abstract] [Full Text] [Related]
5. c-MYC and p53 expression highlight starry-sky pattern as a favourable prognostic feature in R-CHOP-treated diffuse large B-cell lymphoma.
Bouroumeau A; Bussot L; Bonnefoix T; Fournier C; Chapusot C; Casasnovas O; Martin L; McLeer A; Col E; David-Boudet L; Lefebvre C; Algrin C; Raskovalova T; Jacob MC; Vettier C; Chevalier S; Callanan MB; Gressin R; Emadali A; Sartelet H
J Pathol Clin Res; 2021 Nov; 7(6):604-615. PubMed ID: 34374220
[TBL] [Abstract] [Full Text] [Related]
6. The Tumor Microenvironment in Follicular lymphoma: Its Pro-Malignancy Role with Therapeutic Potential.
Watanabe T
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34069564
[TBL] [Abstract] [Full Text] [Related]
7. Epcoritamab induces potent anti-tumor activity against malignant B-cells from patients with DLBCL, FL and MCL, irrespective of prior CD20 monoclonal antibody treatment.
van der Horst HJ; de Jonge AV; Hiemstra IH; Gelderloos AT; Berry DRAI; Hijmering NJ; van Essen HF; de Jong D; Chamuleau MED; Zweegman S; Breij ECW; Roemer MGM; Mutis T
Blood Cancer J; 2021 Feb; 11(2):38. PubMed ID: 33602901
[TBL] [Abstract] [Full Text] [Related]
8. Activity of ibrutinib plus R-CHOP in diffuse large B-cell lymphoma: Response, pharmacodynamic, and biomarker analyses of a phase Ib study.
Schaffer M; Chaturvedi S; Davis C; de Jong J; Aquino R; Oki Y; Fourneau N; Younes A; Balasubramanian S
Cancer Treat Res Commun; 2020; 25():100235. PubMed ID: 33188997
[TBL] [Abstract] [Full Text] [Related]
9. T follicular helper cells in germinal center B cell selection and lymphomagenesis.
Mintz MA; Cyster JG
Immunol Rev; 2020 Jul; 296(1):48-61. PubMed ID: 32412663
[TBL] [Abstract] [Full Text] [Related]
10. Circulating tumor DNA predicts response in Chinese patients with relapsed or refractory classical hodgkin lymphoma treated with sintilimab.
Shi Y; Su H; Song Y; Jiang W; Sun X; Qian W; Zhang W; Gao Y; Jin Z; Zhou J; Jin C; Zou L; Qiu L; Li W; Yang J; Hou M; Xiong Y; Zhou H; Du X; Wang X; Peng B
EBioMedicine; 2020 Apr; 54():102731. PubMed ID: 32304999
[TBL] [Abstract] [Full Text] [Related]
11. Genomic Alterations and MYD88
Jiang S; Qin Y; Gui L; Liu P; Jiang H; Liu B; Yang J; Yang S; He X; Zhou S; Du X; Yi Y; Lin J; Shi Y
Target Oncol; 2020 Apr; 15(2):221-230. PubMed ID: 32239385
[TBL] [Abstract] [Full Text] [Related]
12. Autocrine LTA signaling drives NF-κB and JAK-STAT activity and myeloid gene expression in Hodgkin lymphoma.
von Hoff L; Kärgel E; Franke V; McShane E; Schulz-Beiss KW; Patone G; Schleussner N; Kolesnichenko M; Hübner N; Daumke O; Selbach M; Akalin A; Mathas S; Scheidereit C
Blood; 2019 Mar; 133(13):1489-1494. PubMed ID: 30696620
[TBL] [Abstract] [Full Text] [Related]
13. Pediatric-type nodal follicular lymphoma: a biologically distinct lymphoma with frequent MAPK pathway mutations.
Louissaint A; Schafernak KT; Geyer JT; Kovach AE; Ghandi M; Gratzinger D; Roth CG; Paxton CN; Kim S; Namgyal C; Morin R; Morgan EA; Neuberg DS; South ST; Harris MH; Hasserjian RP; Hochberg EP; Garraway LA; Harris NL; Weinstock DM
Blood; 2016 Aug; 128(8):1093-100. PubMed ID: 27325104
[TBL] [Abstract] [Full Text] [Related]
14. Recurrent mutations in genes involved in nuclear factor-κB signalling in nodal marginal zone lymphoma-diagnostic and therapeutic implications.
van den Brand M; Rijntjes J; Hebeda KM; Menting L; Bregitha CV; Stevens WB; van der Velden WJ; Tops BB; van Krieken JH; Groenen PJ
Histopathology; 2017 Jan; 70(2):174-184. PubMed ID: 27297871
[TBL] [Abstract] [Full Text] [Related]
15. CD160 expression defines a uniquely exhausted subset of T lymphocytes in HTLV-1 infection.
Chibueze CE; Yoshimitsu M; Arima N
Biochem Biophys Res Commun; 2014 Oct; 453(3):379-84. PubMed ID: 25277889
[TBL] [Abstract] [Full Text] [Related]
16. Molecular pathogenesis of follicular lymphoma.
Kishimoto W; Nishikori M
J Clin Exp Hematop; 2014; 54(1):23-30. PubMed ID: 24942943
[TBL] [Abstract] [Full Text] [Related]
17. Chemotherapy for initial induction failures in childhood acute lymphoblastic leukemia: a Children's Oncology Group Study (POG 8764).
Joyce MJ; Pollock BH; Devidas M; Buchanan GR; Camitta B
J Pediatr Hematol Oncol; 2013 Jan; 35(1):32-5. PubMed ID: 23211688
[TBL] [Abstract] [Full Text] [Related]
18. Acquired tnfrsf14 mutations in follicular lymphoma are associated with worse prognosis.
Cheung KJ; Johnson NA; Affleck JG; Severson T; Steidl C; Ben-Neriah S; Schein J; Morin RD; Moore R; Shah SP; Qian H; Paul JE; Telenius A; Relander T; Lam W; Savage K; Connors JM; Brown C; Marra MA; Gascoyne RD; Horsman DE
Cancer Res; 2010 Nov; 70(22):9166-74. PubMed ID: 20884631
[TBL] [Abstract] [Full Text] [Related]